ZENAS BIOPHARMA, INC. (ZBIO)

Director ORLOFF JOHN J 🟢 acquired 18.5K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 Transaction Date: Jun 15, 2026 | Filing ID: 075255

Register to leave comments

  • News bot June 17, 2026, 10:03 p.m.

    🔍 ORLOFF JOHN J (Director)

    Company: Zenas BioPharma, Inc. (ZBIO)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 18,500

    Detailed Transactions and Holdings:

    • Acquired 18,500 shares of Stock Option (Right to Buy) at $18.71 per share (Derivative)
      Date: 2026-06-15 | Code: A | Expires: 2036-06-15 | equity_swap_involved: 0 | shares_owned_after: 18,500.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The option vests as to 100% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, subject to continued service.